药械指南

订阅

MedSci主页 / 所有栏目 / 药械指南

抗抑郁药的药物临床试验指导原则

2019-10-31 国家药品监督管理局药品审评中心（CDE）

抑郁

抗抑郁药的药物临床试验指导原则

中文标题：

抗抑郁药的药物临床试验指导原则

发布机构：

国家药品监督管理局药品审评中心（CDE）

发布日期：

2019-10-31

简要介绍：

抗抑郁药的药物临床试验指导原则

相关资料下载：
[AttachmentFileName(sort=100, fileName=抗抑郁药的药物临床试验指导原则)] GetToolGuiderByIdResponse(projectId=1, id=706201c00181a683, title=抗抑郁药的药物临床试验指导原则, enTitle=, guiderFrom=, authorId=null, author=, summary=抗抑郁药的药物临床试验指导原则, cover=, journalId=null, articlesId=null, associationId=1936, associationName=国家药品监督管理局药品审评中心（CDE）, associationIntro=国家药品监督管理局药品审评中心（CDE）, copyright=0, guiderPublishedTime=Thu Oct 31 04:59:18 CST 2019, originalUrl=, linkOutUrl=, content=抗抑郁药的药物临床试验指导原则, tagList=[TagDto(tagId=1273, tagName=抑郁)], categoryList=[CategoryDto(categoryId=11, categoryName=药械, tenant=100), CategoryDto(categoryId=13, categoryName=精神心理科, tenant=100), CategoryDto(categoryId=67, categoryName=研究设计与统计, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指导原则, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2392, appHits=221, showAppHits=0, pcHits=1199, showPcHits=1625, likes=52, shares=8, comments=9, approvalStatus=1, publishedTime=Thu Oct 31 04:59:18 CST 2019, publishedTimeString=2019-10-31, pcVisible=1, appVisible=1, editorId=4754896, editor=fbzhang, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=fbzhang, createdTime=Thu Oct 31 04:59:18 CST 2019, updatedBy=null, updatedName=null, updatedTime=Fri Jan 05 19:39:38 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=抗抑郁药的药物临床试验指导原则)])
抗抑郁药的药物临床试验指导原则
下载请点击：
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1050117, encodeId=eb3d105011e71, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d3ab5451167, createdName=ms3000000824258724, createdTime=Tue Sep 14 00:52:58 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969199, encodeId=532c969199de, content=謝謝, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210528/a0d2a11691b24091b5b9dbfbadf81dc9/2fdf08a8d767479e869c7752c34716dc.jpg, createdBy=c3915509274, createdName=Ineslou, createdTime=Fri May 28 13:35:51 CST 2021, time=2021-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944622, encodeId=55f09446228f, content=想要呢，我是10几年的老患者了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210302/9338fe5278ab493b99b8122dc7044442/841b963bfa2143a8888aea6a92c5f83d.jpg, createdBy=e4bb5464596, createdName=田幺口阿, createdTime=Tue Mar 02 01:12:26 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812669, encodeId=2c43812669ae, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f85413012, createdName=ms4000001118687736, createdTime=Mon Aug 24 15:29:27 CST 2020, time=2020-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803495, encodeId=d4c680349516, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acee5401612, createdName=ms7000001773953003, createdTime=Mon Jul 20 15:23:14 CST 2020, time=2020-07-20, status=1, ipAttribution=)]
    2021-09-14 ms3000000824258724

    不错

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1050117, encodeId=eb3d105011e71, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d3ab5451167, createdName=ms3000000824258724, createdTime=Tue Sep 14 00:52:58 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969199, encodeId=532c969199de, content=謝謝, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210528/a0d2a11691b24091b5b9dbfbadf81dc9/2fdf08a8d767479e869c7752c34716dc.jpg, createdBy=c3915509274, createdName=Ineslou, createdTime=Fri May 28 13:35:51 CST 2021, time=2021-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944622, encodeId=55f09446228f, content=想要呢，我是10几年的老患者了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210302/9338fe5278ab493b99b8122dc7044442/841b963bfa2143a8888aea6a92c5f83d.jpg, createdBy=e4bb5464596, createdName=田幺口阿, createdTime=Tue Mar 02 01:12:26 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812669, encodeId=2c43812669ae, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f85413012, createdName=ms4000001118687736, createdTime=Mon Aug 24 15:29:27 CST 2020, time=2020-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803495, encodeId=d4c680349516, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acee5401612, createdName=ms7000001773953003, createdTime=Mon Jul 20 15:23:14 CST 2020, time=2020-07-20, status=1, ipAttribution=)]
    2021-05-28 Ineslou

    謝謝

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1050117, encodeId=eb3d105011e71, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d3ab5451167, createdName=ms3000000824258724, createdTime=Tue Sep 14 00:52:58 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969199, encodeId=532c969199de, content=謝謝, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210528/a0d2a11691b24091b5b9dbfbadf81dc9/2fdf08a8d767479e869c7752c34716dc.jpg, createdBy=c3915509274, createdName=Ineslou, createdTime=Fri May 28 13:35:51 CST 2021, time=2021-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944622, encodeId=55f09446228f, content=想要呢，我是10几年的老患者了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210302/9338fe5278ab493b99b8122dc7044442/841b963bfa2143a8888aea6a92c5f83d.jpg, createdBy=e4bb5464596, createdName=田幺口阿, createdTime=Tue Mar 02 01:12:26 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812669, encodeId=2c43812669ae, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f85413012, createdName=ms4000001118687736, createdTime=Mon Aug 24 15:29:27 CST 2020, time=2020-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803495, encodeId=d4c680349516, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acee5401612, createdName=ms7000001773953003, createdTime=Mon Jul 20 15:23:14 CST 2020, time=2020-07-20, status=1, ipAttribution=)]
    2021-03-02 田幺口阿

    想要呢，我是10几年的老患者了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1050117, encodeId=eb3d105011e71, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d3ab5451167, createdName=ms3000000824258724, createdTime=Tue Sep 14 00:52:58 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969199, encodeId=532c969199de, content=謝謝, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210528/a0d2a11691b24091b5b9dbfbadf81dc9/2fdf08a8d767479e869c7752c34716dc.jpg, createdBy=c3915509274, createdName=Ineslou, createdTime=Fri May 28 13:35:51 CST 2021, time=2021-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944622, encodeId=55f09446228f, content=想要呢，我是10几年的老患者了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210302/9338fe5278ab493b99b8122dc7044442/841b963bfa2143a8888aea6a92c5f83d.jpg, createdBy=e4bb5464596, createdName=田幺口阿, createdTime=Tue Mar 02 01:12:26 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812669, encodeId=2c43812669ae, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f85413012, createdName=ms4000001118687736, createdTime=Mon Aug 24 15:29:27 CST 2020, time=2020-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803495, encodeId=d4c680349516, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acee5401612, createdName=ms7000001773953003, createdTime=Mon Jul 20 15:23:14 CST 2020, time=2020-07-20, status=1, ipAttribution=)]
    2020-08-24 ms4000001118687736

    谢谢

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1050117, encodeId=eb3d105011e71, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d3ab5451167, createdName=ms3000000824258724, createdTime=Tue Sep 14 00:52:58 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969199, encodeId=532c969199de, content=謝謝, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210528/a0d2a11691b24091b5b9dbfbadf81dc9/2fdf08a8d767479e869c7752c34716dc.jpg, createdBy=c3915509274, createdName=Ineslou, createdTime=Fri May 28 13:35:51 CST 2021, time=2021-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944622, encodeId=55f09446228f, content=想要呢，我是10几年的老患者了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210302/9338fe5278ab493b99b8122dc7044442/841b963bfa2143a8888aea6a92c5f83d.jpg, createdBy=e4bb5464596, createdName=田幺口阿, createdTime=Tue Mar 02 01:12:26 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812669, encodeId=2c43812669ae, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f85413012, createdName=ms4000001118687736, createdTime=Mon Aug 24 15:29:27 CST 2020, time=2020-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803495, encodeId=d4c680349516, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acee5401612, createdName=ms7000001773953003, createdTime=Mon Jul 20 15:23:14 CST 2020, time=2020-07-20, status=1, ipAttribution=)]
    2020-07-20 ms7000001773953003

    谢谢

    0

相关指南

2018 ESC意见书：抑郁和冠心病

欧洲心脏病学会(ESC,European Society of Cardiology) · 2019-01-28

老年期抑郁障碍诊疗专家共识

中华医学会精神病学分会 · 2017-10-20

【专题】 应对抑郁症，让医患“零”压力的神器竟然是这个！！！

暂未更新 · 2017-03-10

综合医院焦虑、抑郁与躯体化症状诊断治疗的专家共识

中华医学会神经外科学分会 · 2016-12-30

2016 AHA/ASA科学声明：卒中后抑郁

美国心脏协会(AHA,American Heart Association) · 2016-12-01

2016 卒中后抑郁临床实践的中国专家共识

中国医师协会神经内科医师分会 · 2016-08-15